Lydia Soto‐Torres

Dados Biográficos

ID	7727454
NOME	Lydia Soto‐Torres
PRENOMES	Lydia
SOBRENOME	Soto‐Torres
ASSINATURA	TORRES L S
AFILIAÇÕES	National Institutes of Health
VERIFICADO	Não
TOTAL DE OBRAS	18
TOTAL DE CITAÇÕES	0
TOTAL COMO AUTOR	18
TOTAL COMO EDITOR	0
PRIMEIRO ANO DE PUBLICAÇÃO	2012
ANO MAIS RECENTE DE PUBLICAÇÃO	2024
ÍNDICE H	0

Acceptability of the dapivirine vaginal ring for HIV-1 prevention among women reporting engagement in transactional sex
Erica N Browne, Kristine Torjesen et al.ARTICLEAIDS Care2024
We assessed if acceptability of the dapivirine vaginal ring for HIV prevention differed among the subgroup of women who reported engaging in transactional sex prior to enrollment in MTN-020/ASPIRE (phase III trial in Malawi, South Africa, Uganda, and Zimbabwe, 2012-2015; n = 2629). Transactional sex was defined as receipt of money, goods, gifts, drugs, or shelter in exchange for sex in the past year. Dimensions of acceptability included: ease of …
Efficacy of the Dapivirine Vaginal Ring Accounting for Imperfect Adherence
Open AccessMarla Husnik, Renee Heffron et al.ARTICLEAIDS and Behavior2024
Adolescent Girls and Young Women’s Experiences with Disclosing Oral PrEP or Dapivirine Vaginal Ring Use
Open AccessAlinda M Young, Noah Mancuso et al.ARTICLEAIDS and Behavior2023
Effective use of oral pre-exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in Eastern and Southern Africa, partly due to stigma and opposition from key influencers. Understanding AGYW's experiences of disclosure of different PrEP modalities to key influencers may inform strategies to motivate uptake and adherence. We analyzed qualitative in-depth interviews and focus group discussions data from 119 participan…
Correlates of Dapivirine Vaginal Ring Acceptance among Women Participating in an Open Label Extension Trial
Open AccessBrenda Gati Mirembe, Maria Valdez Cabrera et al.ARTICLEAIDS and Behavior2022
Women’s experience receiving drug feedback and adherence counseling in MTN-025/Hope - an HIV Prevention open-label trial of the Dapivirine Vaginal Ring
Open AccessAriana Katz, Iván C Balán et al.ARTICLEAIDS and Behavior2022
Impact and experience of participant engagement activities in supporting dapivirine ring use among participants enrolled in the phase III MTN-020/Aspire study
Open AccessMorgan Garcia, Ellen Luecke et al.ARTICLEBMC Public Health2021
Our analysis supports the growing body of work illustrating the importance of meaningfully engaging research participants to achieve study success and aligns with other analyses of adherence support efforts during ASPIRE. While causation between PEA attendance and product use cannot be established, residual drug levels in returned rings strongly correlated with participant attendance at PEAs, and the benefits of incorporating PEAs should be consi…
Does the Ring Work? Perceptions and Understanding of the Efficacy of a Dapivirine Vaginal Ring for HIV Prevention Amongst Women in a Placebo-Controlled Trial
Open AccessJuliane Etima, Ariana Katz et al.ARTICLEAIDS and Behavior2021
Correlates of Adherence to the Dapivirine Vaginal Ring for HIV-1 Prevention
Open AccessMarla Husnik, Elizabeth R Brown et al.ARTICLEAIDS and Behavior2021
Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial
Open AccessAshley Mayo, Erica N Browne et al.ARTICLEAIDS and Behavior2021
We evaluated the acceptability of the 25 mg dapivirine vaginal ring (DVR) as an HIV prevention intervention and its influence on DVR adherence in the MTN-020/ASPIRE phase III trial. Acceptability measures were captured using ACASI at month 3 and end of product use (median 24 months, IQR 15-30). Monthly returned rings were classified as nonadherent if dapivirine release rate was ≤ 0.9 mg/month. Associations between acceptability measures and nonad…
Implementation of a fidelity monitoring process to assess delivery of an evidence-based adherence counseling intervention in a multi-site biomedical HIV prevention study
Iván C Balán, Cody Lentz et al.ARTICLEAIDS Care2020
Pre-Exposure Prophylaxis (PrEP) trials often implement counseling to support product adherence. Counseling fidelity can vary significantly across providers and time. Fidelity monitoring can ensure that counseling is delivered as designed. We describe the process, feasibility, and outcomes of monitoring Options counseling fidelity in an open-label study of the dapivirine vaginal ring MTN-025/HOPE. After initial training, 63 counselors from 14 site…
Client-Centered Adherence Counseling with Adherence Measurement Feedback to Support Use of the Dapivirine Ring in MTN-025 (The Hope Study)
Open AccessIván C Balán, Rebecca Giguere et al.ARTICLEAIDS and Behavior2020
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women
Jared M Baeten, Thesla Palanee‐phillip et al.ARTICLENew England Journal of Medicine2016
BACKGROUND: Antiretroviral medications that are used as prophylaxis can prevent acquisition of human immunodeficiency virus type 1 (HIV-1) infection. However, in clinical trials among African women, the incidence of HIV-1 infection was not reduced, probably because of low adherence. Longer-acting methods of drug delivery, such as vaginal rings, may simplify use of antiretroviral medications and provide HIV-1 protection. METHODS: We conducted a ph…
Adherence and Acceptability of a Multidrug Vaginal Ring for HIV Prevention in a Phase I Study in the United States
Open AccessAriane Van Der Straten, Lori Panther et al.ARTICLEAIDS and Behavior2016
Sexual Behaviors of US Women at Risk of HIV Acquisition
Open AccessJessica Justman, Montina Befus et al.ARTICLEAIDS and Behavior2015
Women’s Experiences with Oral and Vaginal Pre-Exposure Prophylaxis
Open AccessAriane Van Der Straten, Jonathan Stadler et al.ARTICLEPLoS ONE2014
BACKGROUND: In VOICE, a multisite HIV pre-exposure prophylaxis (PrEP) trial, plasma drug levels pointed to widespread product nonuse, despite high adherence estimated by self-reports and clinic product counts. Using a socio-ecological framework (SEF), we explored socio-cultural and contextual factors that influenced participants' experience of daily vaginal gel and oral tablet regimens in VOICE. METHODS: In Johannesburg, a qualitative ancillary s…
Male Partner Influence on Women’s HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis
Open AccessElizabeth Montgomery, Ariane Van Der Straten et al.ARTICLEAIDS and Behavior2014
Prevalence and Correlates of Knowledge of Male Partner HIV Testing and Serostatus Among African-American Women Living in High Poverty, High HIV Prevalence Communities (HPTN 064)
Open AccessLarissa Jennings, Anne Rompalo et al.ARTICLEAIDS and Behavior2014
Adherence and Acceptability in MTN 001
Open AccessAlexandra M Minnis, Sharavi Gandham et al.ARTICLEAIDS and Behavior2012